NMTC
NeuroOne Medical Technologies Corporation (NASDAQ)
Healthcare — Medical Devices
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology's Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.
Price History
Fundamentals
| Market Cap | $26.11M |
| P/E Ratio (TTM) | - |
| Forward P/E | -10.71 |
| EPS (TTM) | $-0.89 |
| Dividend Yield | - |
| Profit Margin | -52.23% |
| Revenue Growth | 72.50% |
| ROE | -204.44% |
| Debt/Equity | 3.85 |
| Recommendation | Strong Buy 1.3 |
| Analyst Target | $9.93 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 35.0 |
| Beta | 0.51 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $6.96 |
| 52-Week Low | $2.89 |
| 50-Day Avg | $3.92 |
| 200-Day Avg | $4.53 |
| Avg Volume | 38.8K |
| Volume | 44.3K |
Performance Analysis
BULLISHNMTC shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:22 UTC
Back to Screener Export Report